Maas et al. 199042 n = 58 |
|
|
Fewer NAS symptoms, lower PTD rate, higher body weight, longer pregnancies among women who abstained, followed by women who underwent MMT, compared with women who continued to use heroin
|
Dashe et al. 199840 n = 34 | Stabilization
Taper
|
Abstinence: 59% MMT: 12% Illicit drug use: 29%
|
|
Luty et al. 200343 n = 101 |
21-d inpatient methadone taper 51 women lost to follow-up Complete records for 24 women and 22 infants
|
|
|
Jones et al. 200844 n = 123 | 3-d methadone taper (n = 75)
7-d methadone taper (n = 48)
|
Abstinence: 47% (3-d taper) and 43% (7-d taper) MMT: 11% (3-d taper) and 42% (7-d taper) Illicit drug use: 53% (3-d taper) and 57% (7-d taper) vs. 23% in control group receiving MMT
|
|
Stewart et al. 201341 n = 95 | Stabilization
Taper
|
Abstinence: 56% MMT: 18% Illicit drug use: 44%
|
NAS: Lower Finnegan scores, shorter stays in hospital and less treatment PTD: No difference Stillbirth: 2 (mothers were actively using heroin)
|